The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Switzerland-based CeQur has completed a $120m equity financing round to support the ongoing commercialisation efforts for its ...

CeQur announced today that it closed a $120 million financing round to support its wearable insulin delivery technology.

Fast Company Executive Board member Dev Kurdikar advocates for defining a clear mission statement to be an organization’s ...

CHICAGO, NY, UNITED STATES, January 17, 2025 /EINPresswire / -- The global insulin pump <a target=_blank href= ...

Insulet Corporation PODD recently made its Omnipod 5 automated insulin delivery system commercially available in five more ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

Beta Bionics is commercializing innovative insulin delivery technologies, but faces challenges in achieving profitability.

The convergence of advanced technologies and advancements in drug delivery is reshaping diabetes care. Digital therapeutics ...

Explore the collaboration between UVA Center for Diabetes Technology and Tandem Diabetes Care to transform insulin delivery ...

The market is mainly driven by the growing prevalence of diabetes, the rising usage of insulin-delivery devices and high obesity rates. The market is characterized by a high degree of innovation ...